echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > A novel drug for the treatment of glioblastoma in children

    A novel drug for the treatment of glioblastoma in children

    • Last Update: 2022-10-03
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Johanna Wyss of the Aarau Children's Oncology Center in Switzerland and others introduced new drugs that can currently be used for GBM in children, and the article was published online in June 2022 in Cancers



    ——Excerpt from the article chapter

    【Ref: Wyss J, et al.



    Research background

    Glioblastoma (GBM) in children accounts for 2.



    Investigators systematically searched PubMed and Embase data for relevant English-language literature published between 2010 and 2021, including randomized controlled trials, cohort studies, and case series



    Results of the study

    The study selected six from 1122 clinical study reports as results




    The findings suggest that the efficacy of the drug in treating GBM in children is unclear, and there are currently no new drugs that can significantly improve overall or progression-free survival in children with GBM



    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.